254
Participants
Start Date
August 2, 2019
Primary Completion Date
October 27, 2022
Study Completion Date
October 27, 2022
No intervention
No intervention will be administered as a part of this study.
Universitair Ziekenhuis Antwerpen, Edegem
UZ Leuven, Leuven
Ucl de Mont-Godinne, Yvoir
Grand Hopital de Charleroi, site Notre Dame, Charleroi
Hosp. Univ. Son Espases, Palma
A.O.U. Citta della Salute e della Scienza di Torino - Presidio Molinette, Turin
Hosp. Puerta Del Mar, Cadiz
Hosp. de Jerez de La Frontera, Jerez de la Frontera
The Cancer Institute at St. Francis Hospital, East Hills
North Shore Hematology Oncology Associates, P.C., East Setauket
IRCCS Azienda Ospedaliera San Martino - IST, Genova
Universitätsklinik Hamburg-Eppendorf - Orthopädische Universitätsklinik und Poliklinik, Hamburg
Hosp. de Leon, León
Fondazione IRCCS Policlinico San Matteo, Pavia
Hosp. Univ. Ramon Y Cajal, Madrid
Hosp. Univ. 12 de Octubre, Madrid
Clinica Univ. de Navarra, Pamplona
Pôle IUC Oncopole CHU, Toulouse
CHU de Montpellier Hopital Saint Eloi, Montpellier
Asclepes Research, Weeki Wachee
Universita degli Studi di Padova Azienda Ospedaliera di Pa, Padua
Hosp Clinico Univ de Salamanca, Salamanca
Hosp. Univ. Marques de Valdecilla, Santander
Istituto di Ematologia Seràgnoli azienda ospedaliera univeristaria Policlinico S.Orsola-Malpighi, Bologna
The Ohio State University, Columbus
C.H.U. Hotel Dieu - France, Nantes
Hosp. Univ. Dr. Peset, Valencia
Hosp. Clinico Univ. de Valladolid, Valladolid
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola
Providence Cancer Center, Southfield
Medizinische Klinik A, Münster
Azienda Ospedaliera Universitaria Careggi, Florence
Universitaetsklinikum Koelnt, Cologne
Centre Hospitalier Régional Universitaire de Lille, Hôpital Claude Huriez, Lille
Oncology Hematology Assoc of Central Illinois, P.C. d.b.a. Illinois CancerCare, P.C., Peoria
Washington University School Of Medicine, St Louis
Central Care Cancer Center, Bolivar
Universitaetsklinikum Heidelberg, Heidelberg
Centre hospitalier Lyon-Sud, Pierre-Bénite
U.O. Ematologia con Trapianto- AOU Policlinico di Bari, Bari
U.O. Ematologia Istituto Tumori Giovanni Paolo II, Bari
IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo
Centre Hospitalier du Mans, Le Mans
Klinikum der Eberhard Karls Universitaet Abt fur innere Med II Haematologie Onkologie Germany, Tübingen
Ospedale Cardinale G. Panico, Tricase
Hopital Saint Louis, Paris
Hopital Saint-Antoine, Paris
Irccs Crob, Rionero in Vulture
CHU Poitiers - Hopital la Miletrie, Poitiers
Optum Care, Las Vegas
Ospedale Villa Sofia-Cervello, Palermo
Oncology Institute of Hope and Innovation, Glendale
Marin Cancer Center, Greenbrae
Policlinico di Catania, Catania
Universitatsklinikum Wurzburg, Würzburg
S.P. Botkin Moscow City Clinical Hospital, Moscow
Clinical Research Institute of Hematology and Transfusiology, Saint Petersburg
Samara Region Clinical Hospital, Samara
Hunterdon Hematology Oncology, Flemington
Università di Roma La Sapienza, Roma
Fondazione Policlinico Universitario A Gemelli IRCCS, Roma
VU Medisch Centrum, Amsterdam
UMCG, Groningen
Erasmus MC - Satellite, Rotterdam
Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie, Lublin
Szpital Kliniczny im H Swiecickiego Uniwersytetu Medycznego im K Marcinkowskiego w Poznaniu, Poznan
Inst. Cat. Doncologia-H Duran I Reynals, Barcelona
Hosp. Mutua Terrassa, Terrassa
Birmingham Heartlands Hospital, Birmingham
Southmead Hospital, Bristol
Maidstone Hospital, Kent
Kings College Hospital, London
St George's Hospital, London
Nottingham University Hospitals NHS Trust, Nottingham
The Royal Marsden NHS Trust Sutton, Surrey
Collaborators (1)
Legend Biotech
UNKNOWN
Janssen-Cilag Ltd.
INDUSTRY